Cardiac Actions of Erythromycin
Open Access
- 25 November 1998
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 280 (20) , 1774-1776
- https://doi.org/10.1001/jama.280.20.1774
Abstract
ERYTHROMYCIN is a widely used macrolide antibiotic for which lengthening of the rate-corrected QT interval (QTc) on the electrocardiogram (ECG) has been reported.1,2 A prolonged QTc interval on the ECG is a feature associated with drug-induced torsades de pointes (TdP), an arrhythmia reported in patients treated with erythromycin.3-6Keywords
This publication has 7 references indexed in Scilit:
- Age-Gender Influence on the Rate-Corrected QT Interval and the QT-Heart Rate Relation in Families With Genotypically Characterized Long QT SyndromeJournal of the American College of Cardiology, 1997
- Gender-Specific Differences in the QT Interval and the Effect of Autonomic Tone and Menstrual Cycle in Healthy AdultsThe American Journal of Cardiology, 1997
- Cellular and Ionic Mechanisms Underlying Erythromycin-Induced Long QT Intervals and Torsade de PointesJournal of the American College of Cardiology, 1996
- Sex Difference in Risk of Torsade de Pointes With d,l- SotalolCirculation, 1996
- Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndromeThe American Journal of Cardiology, 1987
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984
- Intersubject and dose‐related variability after intravenous administration of erythromycin.British Journal of Clinical Pharmacology, 1980